Global Anti- inflammatory Therapeutics Market: Overview
Also known as non-steroidal anti- inflammatory drugs, anti-inflammatory therapeutics help in easing acute and mild chronic pain. Be it migraines and headaches, rheumatic arthritis, sprains, or even menstrual pain, anti- inflammatory therapeutics can provide faster relief as compared with other drugs. They are capable of lowering the levels of prostaglandins, the chemicals responsible for inflammation, reducing pain and swelling.
Aspirin, acelofenac, celecoxib, etoricoxib, acemetacin, etodolac, ibuprofen, Meloxicam, tenoxicam, dexketoprofen, fenoprofen, sulindac, naproxen, dexibuprofen, and mefenamic acid are some anti-inflammatory painkillers. By class, immune selective anti-inflammatory derivatives and non-steroidal anti-inflammatory drugs are the two major categories in the global market for anti-inflammatory therapeutics.
Obtain Report Details @
The report by Transparency Market Research (TMR) analyzes the key aspects of the global anti- inflammatory therapeutics market, offering a 360 degree view. The prominent regions, leading segments, and market attractiveness have been discussed in detail in the report, with an aim to address the needs of the buyers.
Global Anti-inflammatory Therapeutics Market: Drivers and Restraints
As the incidence of respiratory diseases and autoimmune conditions is rising globally, the demand for anti-inflammatory therapeutics is expected to increase. According to the findings of the Rheumatoid Arthritis Support Network (RASN), more than 1.3 million people in the U.S. suffer from rheumatoid arthritis. On a global scale, almost 1% of the population is diagnosed with this disorder. As the treatment and cure for this autoimmune disease is still unknown, the only possible way of easing pain is the intake of anti-inflammatory therapeutics. As a result, the global market for these drugs is slated to witness considerable growth.
Enquiry for Discount on this Report @
Moreover, anti-inflammatory therapeutics offer cost efficient remedies. New drugs are being developed for relieving depression and treating ocular pain. Recent studies have revealed that consumption of anti-inflammatory drugs can confer protection against Parkinson’s disease.
On the other hand, the risk of cardiovascular disorders associated with the heavy intake of these medications might restrict growth. The market might also face challenges due to the side effects of these drugs such as nausea, dizziness, headaches, and diarrhea. The expiry of parents is another key restraint of the market. However, as new drugs with superior effectiveness are being developed by several leading manufacturers, significant opportunities will arise.
Request Report Brochure @
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companyâ€™s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRâ€™s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]